PT-141 PNC27 10mg*10vials

PT-141 PNC27 10mg*10 vials belongs to the CN peptide neuroendocrine and physiological regulation series. It is a high-efficiency, enhanced flagship product and the flagship product of the synthetic peptide Bremellanotide. PNC27 is a potent and selective MC4R melanocortin receptor agonist with excellent blood-brain barrier permeability and zero immunogenicity. The 10mg high-dose formulation enhances central neuroendocrine regulatory efficacy. Unlike single vasomotor agents, PT-141 targets the hypothalamic-limbic reward pathway and the autonomic nervous system, providing dual physiological regulation of neurobehavioral responses and pelvic microcirculation. This high-concentration formulation is specifically designed for advanced preclinical studies such as neuroregulation, energy metabolism balance, central inflammatory protection, and validation of peptide physiological synergies. It is a core upgraded research material for research on neuroendocrine behavioral mechanisms and metabolic physiology.

Product Functions and Research Value

PT-141 PNC27 possesses four core high-amplitude regulatory effects, suitable for in-depth laboratory research: activating central MC4R receptors, regulating limbic system reward signals, promoting dopamine release, and improving neurobehavioral motivational responses; dilating pelvic microvessels, enhancing local blood perfusion, stabilizing autonomic nervous system regulation, and optimizing physiological arousal responses; regulating the hypothalamic energy metabolism axis, inhibiting excessive appetite signals, improving energy consumption balance, and supporting research on metabolic regulation and weight mechanisms; and exerting a mild central nervous system protective effect, inhibiting excessive microglial cell activation and low-grade neuroinflammation, and alleviating cumulative neurological stress damage. Dysfunction of the central melanocortin pathway, insufficient pelvic microcirculation, and energy metabolism imbalance are key factors leading to neuroendocrine behavioral disorders and metabolic sub-health. Compared to low-dose formulations, the 10mg high-concentration PNC27 formulation achieves stronger pathway activation and more thorough physiological remodeling, providing highly discriminative, stable, and reproducible authoritative data for advanced preclinical research in the fields of neuroendocrine behavior and metabolic physiology.

Core Product Advantages

1. Precise Activation of Central MC4R Targets: A highly selective melanocortin receptor agonist that stably activates the central reward pathway, providing a reliable intervention model for neurobehavioral regulation research.

2. Pelvic Microcirculation and Autonomic Nervous System Optimization: Effectively promotes local vasodilation and blood perfusion, stabilizes autonomic nerve function, and supports research on physiological microcirculation remodeling mechanisms.

3. Energy Metabolism and Appetite Regulation: Regulates hypothalamic metabolic signals, balances energy intake and expenditure, and adapts to preclinical models related to metabolic balance and weight regulation.

4. Mild Neuroinflammatory Protection: Inhibits low-grade inflammation in the central nervous system, alleviates excessive microglial activation, protects the stability of the neural microenvironment, and assists in research on neuroprotective mechanisms.

5. High Purity and Activity Stability: Utilizes upgraded gradient deep purification and vacuum freeze-drying technology, resulting in extremely low background impurities and complete preservation of the active peptide structure, ensuring high stability and reproducibility of experimental data. Premium Aseptic QC Packaging: 10 vials per pack in a dust-free, aseptic integrated packaging, fully tested for purity by HPLC and accompanied by a complete Certificate of Authorization (COA), suitable for high-standard neuroendocrine research and high-end bulk custom procurement.

PT-141 PNC27 10mg*10 vials belongs to the CN peptide neuroendocrine and physiological regulatory peptide series. It is a high-efficiency enhanced flagship product, belonging to the Bremerano peptide synthetic peptide category. This product is a highly selective MC4R melanocortin receptor agonist with excellent blood-brain barrier penetration, zero immunogenicity, and extremely strong biocompatibility. A high loading dose of 10mg can significantly enhance the activation efficiency of central pathways, exceeding the upper limit of basal dose intervention. This product targets the hypothalamic-limbic system reward pathway and the autonomic nervous system, achieving multi-dimensional progressive regulation of neurobehavioral control, optimization of pelvic microcirculation, energy metabolism balance, and central anti-inflammatory protection. It is suitable for research scenarios such as advanced neurobehavioral mechanisms, physiological microcirculation remodeling, metabolic balance regulation, and verification of peptide physiological synergistic effects, making it a core upgraded raw material.